Neurovascular dysfunction, as an integral part of Alzheimer's disease, may have an
important influence on the onset and progression of chronic neurodegenerative processes …

Neurovascular dysfunction, as an integral part of Alzheimer's disease, may have an
important influence on the onset and progression of chronic neurodegenerative processes …

Deposition of amyloid β (Aβ) in the central nervous system (CNS) occurs during normal
aging and is accelerated by Alzheimer's disease. Aβ accumulation in the CNS is considered …

β 淀粉样蛋白(amyloid beta-peptides, Aβ) 是阿尔茨海默病(Alzheimer's disease, AD)
的主要病理特征. Aβ 在患者脑内的积聚由多种因素诱导, 其中血脑屏障(blood-brain barrier …

Blood-brain barrier (BBB) endothelial cells lining the cerebral microvasculature maintain
dynamic equilibrium between soluble amyloid-β (A β) levels in the brain and plasma. The …

Amyloid β-protein (Aβ) is deposited as senile plaques and vascular amyloid in the brain of
patients with Alzheimer's disease as well as in a significant proportion of non-demented …

The origin of amyloid β (Aβ) deposited in brain and cerebral blood vessels of patients with
Alzheimer′ s Disease (AD) is not known. In this study, we tested whether soluble Aβ (sAβ) …

Although the diverse triggers of AD are still under debate, the hypothesis of the contribution
of cerebrovascular deficiencies has emerged in recent years. Cerebrovascular dysfunction …

Amyloid-β (Aβ) accumulation in Alzheimer's disease (AD) and cerebral amyloid angiopathy
(CAA) is likely caused by the impairment of its brain clearance that partly occurs through the …

Senile amyloid plaques are one of the diagnostic hallmarks of Alzheimer's disease (AD).
However, the severity of clinical symptoms of AD is weakly correlated with the plaque load …